Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review

BACKGROUND: Patients may experience nausea and vomiting when undergoing chemotherapy or surgery requiring anesthesia. Serotonin 5-hydroxytryptamine 3 (5-HT3) receptor antagonists are effective antiemetics, yet may cause adverse cardiac events, such as arrhythmia. We aimed to identify interventions t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pharmacol Toxicol
Main Authors: Tricco, Andrea C, Soobiah, Charlene, Hui, Wing, Antony, Jesmin, Struchkov, Vladi, Hutton, Brian, Hemmelgarn, Brenda, Moher, David, Straus, Sharon E
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417335/
https://ncbi.nlm.nih.gov/pubmed/25623303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-16-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados